Search
Mersana Therapeutics Inc
MRSNAdd to Watchlist
29.080USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
145.36MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-01-05The current earnings forecast score of Mersana Therapeutics Inc is 6.25, ranking 343 out of 401 in the Biotechnology & Medical Research industry. The average price target is 29.00, with a high of 50.00 and a low of 27.25.
No Data
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Mersana Therapeutics Inc's expected revenue for the next quarter?
Mersana Therapeutics Inc's expected revenue is 5.44M.
What is Mersana Therapeutics Inc's price target?
Analysts forecast that Mersana Therapeutics Inc's price target is USD 29.00, with the highest forecast at USD 50.00 and the lowest forecast at USD 27.25.
How have Mersana Therapeutics IncMRSN's recent earnings per share performed?
The market expectation was USD -1.51, while Mersana Therapeutics IncMRSN's earnings per share (EPS) for the previous quarter was USD -4.87. EPS for the next quarter is expected at USD -3.24.